Compounds > fenofibrate

fenofibrate and drf 2725

fenofibrate has been researched along with drf 2725 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrektsen, T; Bury, PS; Din, N; Fleckner, J; Frederiksen, KS; Jeppesen, L; Mogensen, JP; Mortensen, SB; Nehlin, J; Pettersson, I; Sauerberg, P; Svensson, LA; Wassermann, K; Wulff, EM; Ynddal, L1
Henke, BR1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Jensen, PB; Larsen, LK; Larsen, PJ; Sørensen, RV; Vrang, N; Wassermann, K; Wulff, EM1
Chakrabarti, R; Cynthia, G; Kumari, M; Sharma, S; Sowjanya, A; Suresh, J; Suryaprakash, R1
Chopra, B; Georgopoulos, NT; Hinley, J; Nicholl, A; Oleksiewicz, MB; Southgate, J1

Reviews

1 review(s) available for fenofibrate and drf 2725

ArticleYear
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
    Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17

    Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2004

Other Studies

7 other study(ies) available for fenofibrate and drf 2725

ArticleYear
Design and synthesis of novel PPARalpha/gamma/delta triple activators using a known PPARalpha/gamma dual activator as structural template.
    Bioorganic & medicinal chemistry letters, 2003, Jan-20, Volume: 13, Issue:2

    Topics: Animals; Blood Glucose; Glucose Tolerance Test; Insulin; Male; Mice; Models, Molecular; Molecular Conformation; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Transcription Factors

2003
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis.
    Diabetes, 2003, Volume: 52, Issue:9

    Topics: Adipose Tissue; Animals; Biomarkers; Blood Glucose; Eating; Energy Metabolism; Fenofibrate; Gene Expression; Glucose Tolerance Test; Glycated Hemoglobin; Homeostasis; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Lipids; Liver; Male; Obesity; Organ Size; Oxazines; Phenylpropionates; Pioglitazone; Rats; Rats, Mutant Strains; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Weight Gain

2003
Biochemical mechanism of insulin sensitization, lipid modulation and anti-atherogenic potential of PPAR alpha/gamma dual agonist: Ragaglitazar.
    Life sciences, 2006, Dec-23, Volume: 80, Issue:3

    Topics: Adipocytes; Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fenofibrate; Gene Expression Regulation; Hepatocytes; Humans; Hypolipidemic Agents; Inflammation Mediators; Insulin Resistance; Lipid Metabolism; Macrophages; Mice; Oxazines; Phenylpropionates; PPAR alpha; PPAR gamma; Rats

2006
Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
    Cell proliferation, 2009, Volume: 42, Issue:5

    Topics: Apoptosis; Calcium; Calcium Channels; Caspase 3; Caspase 9; Cell Division; Cells, Cultured; Chromans; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Fenofibrate; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Membrane Potential, Mitochondrial; Oxazines; p38 Mitogen-Activated Protein Kinases; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; Phenylpropionates; Rosiglitazone; Thiazolidinediones; Troglitazone; Urothelium

2009